Highbridge Capital Management’s Celgene Corp CELG Stock Holding History

Highbridge Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,500	Closed	-$200K	–	1049
2018 Q2	$200K	Buy	+2,500	New	+$208K	﹤0.01%	830
2018 Q1	–	Sell	-22,700	Closed	-$2.37M	–	2002
2017 Q4	$2.37M	Buy	22,700 +16,800	+285%	+$1.9M	0.04%	360
2017 Q3	$861K	Buy	5,900 +3,700	+168%	+$504K	0.01%	661
2017 Q2	$286K	Buy	+2,200	New	+$270K	﹤0.01%	981
2016 Q3	–	Sell	-18,500	Closed	-$1.82M	–	1938
2016 Q2	$1.82M	Sell	18,500 -20,500	-53%	-$2.12M	0.03%	458
2016 Q1	$3.9M	Buy	39,000 +30,400	+353%	+$3.13M	0.06%	349
2015 Q4	$1.03M	Buy	+8,600	New	+$995K	0.02%	744
2015 Q3	–	Sell	-2,300	Closed	-$266K	–	2067
2015 Q2	$266K	Buy	+2,300	New	+$263K	﹤0.01%	1183
2014 Q4	–	Sell	-3,100	Closed	-$294K	–	1679
2014 Q3	$294K	Buy	+3,100	New	+$280K	﹤0.01%	1005
2013 Q4	–	Sell	-14,000	Closed	-$1.08M	–	1605
2013 Q3	$1.08M	Sell	14,000 -19,600	-58%	-$1.37M	0.01%	654
2013 Q2	$1.97M	Buy	+33,600	New	+$2.02M	0.02%	498

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highbridge Capital Management's CELG Position: Q2 2019 in Review

Highbridge Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 187,065 shares — an estimated $17.6M sold.

Highbridge Capital Management first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $53.6M in Q1 2014. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Highbridge Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Highbridge Capital Management sold 187,065 Celgene Corp shares in Q2 2019, an estimated $17.6M.
Highbridge Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
Highbridge Capital Management's Celgene Corp position peaked at $53.6M in Q1 2014.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Highbridge Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.